EXPAREL Dose-Response for Single-Injection Femoral Nerve Blocks

Completed · Phase 1

Conditions studied: Healthy Volunteers

In brief

EXPAREL™, an investigational drug product, is a new formulation of a local anesthetic (numbing medicine) that is designed to be longer acting than the currently-available local anesthetics. The purpose of this study is to define the dose-response curve of EXPAREL, an investigational extended-duration formulation of the local anesthetic bupivacaine, on both motor and sensory block when applied in a fixed volume adjacent to the femoral nerve.

Key facts

Study ID
NCT01349140
Run by
University of California, San Diego
People needed
14
Starts
2012-02-01
Expected to finish
2012-04-01
Last updated by the study team
2021-03-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.